These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 28165371)

  • 21. Experimental In Vivo Models of Bacterial Shiga Toxin-Associated Hemolytic Uremic Syndrome.
    Jeong YJ; Park SK; Yoon SJ; Park YJ; Lee MS
    J Microbiol Biotechnol; 2018 Sep; 28(9):1413-1425. PubMed ID: 29926707
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The pathogenic mechanisms of Shiga toxin and the Shiga-like toxins.
    Tesh VL; O'Brien AD
    Mol Microbiol; 1991 Aug; 5(8):1817-22. PubMed ID: 1766367
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cloned Shiga toxin 2 B subunit induces apoptosis in Ramos Burkitt's lymphoma B cells.
    Marcato P; Mulvey G; Armstrong GD
    Infect Immun; 2002 Mar; 70(3):1279-86. PubMed ID: 11854211
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new biological agent for treatment of Shiga toxigenic Escherichia coli infections and dysentery in humans.
    Paton AW; Morona R; Paton JC
    Nat Med; 2000 Mar; 6(3):265-70. PubMed ID: 10700227
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathogenesis of Shigella diarrhea: XVII. A mammalian cell membrane glycolipid, Gb3, is required but not sufficient to confer sensitivity to Shiga toxin.
    Jacewicz MS; Mobassaleh M; Gross SK; Balasubramanian KA; Daniel PF; Raghavan S; McCluer RH; Keusch GT
    J Infect Dis; 1994 Mar; 169(3):538-46. PubMed ID: 8158025
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Live attenuated Shigella dysenteriae type 1 vaccine strains overexpressing shiga toxin B subunit.
    Wu T; Grassel C; Levine MM; Barry EM
    Infect Immun; 2011 Dec; 79(12):4912-22. PubMed ID: 21969003
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic Antibodies Against Shiga Toxins: Trends and Perspectives.
    Henrique IM; Sacerdoti F; Ferreira RL; Henrique C; Amaral MM; Piazza RMF; Luz D
    Front Cell Infect Microbiol; 2022; 12():825856. PubMed ID: 35223548
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Shiga toxin B subunits induce VWF secretion by human endothelial cells and thrombotic microangiopathy in ADAMTS13-deficient mice.
    Huang J; Motto DG; Bundle DR; Sadler JE
    Blood; 2010 Nov; 116(18):3653-9. PubMed ID: 20644116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endocytosis and retrograde transport of Shiga toxin.
    Sandvig K; Bergan J; Dyve AB; Skotland T; Torgersen ML
    Toxicon; 2010 Dec; 56(7):1181-5. PubMed ID: 19951719
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human monocytes stimulated by Shiga toxin 1a via globotriaosylceramide release proinflammatory molecules associated with hemolytic uremic syndrome.
    Brigotti M; Carnicelli D; Arfilli V; Porcellini E; Galassi E; Valerii MC; Spisni E
    Int J Med Microbiol; 2018 Oct; 308(7):940-946. PubMed ID: 29983334
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Valid Presumption of Shiga Toxin-Mediated Damage of Developing Erythrocytes in EHEC-Associated Hemolytic Uremic Syndrome.
    Detzner J; Pohlentz G; Müthing J
    Toxins (Basel); 2020 Jun; 12(6):. PubMed ID: 32512916
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Shiga toxin-associated hemolytic uremic syndrome: effect of sodium butyrate on sensitivity of human umbilical vein endothelial cells to Shiga toxin.
    Louise CB; Kaye SA; Boyd B; Lingwood CA; Obrig TG
    Infect Immun; 1995 Jul; 63(7):2766-9. PubMed ID: 7790096
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A single VHH-based toxin-neutralizing agent and an effector antibody protect mice against challenge with Shiga toxins 1 and 2.
    Tremblay JM; Mukherjee J; Leysath CE; Debatis M; Ofori K; Baldwin K; Boucher C; Peters R; Beamer G; Sheoran A; Bedenice D; Tzipori S; Shoemaker CB
    Infect Immun; 2013 Dec; 81(12):4592-603. PubMed ID: 24082082
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Role of
    Menge C
    Toxins (Basel); 2020 Sep; 12(9):. PubMed ID: 32967277
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Shiga Toxin Induces Lipid Compression: A Mechanism for Generating Membrane Curvature.
    Watkins EB; Majewski J; Chi EY; Gao H; Florent JC; Johannes L
    Nano Lett; 2019 Oct; 19(10):7365-7369. PubMed ID: 31538793
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunological detection assays for recombinant Shiga toxin &
    Gupta P; Dhaked RK
    Indian J Med Res; 2019 Mar; 149(3):412-417. PubMed ID: 31249208
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phage display and Shiga toxin neutralizers.
    Bernedo-Navarro RA; Yano T
    Toxicon; 2016 Apr; 113():60-9. PubMed ID: 26898657
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Shiga toxin mode of action in E. coli O157:H7 disease.
    Obrig TG
    Front Biosci; 1997 Dec; 2():d635-42. PubMed ID: 9392626
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The A1 Subunit of Shiga Toxin 2 Has Higher Affinity for Ribosomes and Higher Catalytic Activity than the A1 Subunit of Shiga Toxin 1.
    Basu D; Li XP; Kahn JN; May KL; Kahn PC; Tumer NE
    Infect Immun; 2016 Jan; 84(1):149-61. PubMed ID: 26483409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Shiga Toxins as Antitumor Tools.
    Robert A; Wiels J
    Toxins (Basel); 2021 Sep; 13(10):. PubMed ID: 34678982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.